The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific
Rainima-Qaniuci, Merelesita, Lepaitai, Hansell Blanche, Bhagirov, Rasul, Padmasiri, Eswara, Naseri, Take, Thomsen, Robert, Won, Kimberly Y., Brant, Tara A., Dodd, Emily, Nua, Motusa Tuileama, Utu, Fara, Tufa, Aifili, Chutaro, Emi, Camacho, Janet, Suiaunoa-Scanlan, Lynette, Thean, Li Jun, Mani, Jyotishna, Hardy, Myra, Samuela, Josaia, Romani, Lucia, Kaldor, John, Steer, Andrew C., Faktaufon, Daniel, Bechu, Vinaisi, Naqio, Flora, Sosene, Vine, Sekihara, Makoto, Otaki, Junko, Buhagiar, Tamara S., and Yajima, Aya (2022) The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific. American Journal of Tropical Medicine and Hygiene, 106 (5). pp. 39-47.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (736kB) | Preview |
Abstract
We discuss the experience of some Pacific island countries in introducing the new WHO-recommended treatment protocol for lymphatic filariasis—a triple-drug therapy composed of ivermectin, diethylcarbamazine, and albendazole. The successful rollout of the new treatment protocol was dependent on strong partnerships among these countries’ ministries of health, WHO, and other stakeholders. Effective communication among these partners allowed for lessons learned to cross borders and have a positive impact on the experiences of other countries. We also describe various challenges confronted during this process and the ways these countries overcame them.
| Item ID: | 74422 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 1476-1645 |
| Copyright Information: | © 2022 The American Journal of Tropical Medicine and Hygiene. This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| Date Deposited: | 08 Jun 2022 07:44 |
| FoR Codes: | 42 HEALTH SCIENCES > 4202 Epidemiology > 420207 Major global burdens of disease @ 50% 32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320211 Infectious diseases @ 50% |
| SEO Codes: | 20 HEALTH > 2001 Clinical health > 200105 Treatment of human diseases and conditions @ 50% 20 HEALTH > 2004 Public health (excl. specific population health) > 200404 Disease distribution and transmission (incl. surveillance and response) @ 50% |
| Downloads: |
Total: 535 Last 12 Months: 5 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |